About Kobo Biotech Limited
Data last updated: 30 July 2025
Kobo Biotech Limited is a public limited company based in Hyderabad, Telangana, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 August 1993, the company has been in operation for over 33 years.
Registered with ROC Hyderabad under CIN L24110TG1993PLC016112. Listed on BSE: 531541.
Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹23.83 Cr. Formerly known as Kobo Biotech Limited and Avon Organics Ltd. It is led by directors including Sunil Mansukhlal Pitroda and Ajit Annu Kamath.
Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.52 Lakh, a decline of 8% compared to the previous year.
The company has a workforce of approximately 1 employees as per the latest available data.
The company is associated with 2 brands - Kobo Biotech, Avon Organics. As per MCA filings, the company has open charges of ₹169.36 Cr and satisfied charges of ₹145.09 Cr on record.
The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments. The last known website on record is kobobiotech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No. 121A/1 Western Hills Addagutta Society Opp. Jntu Kukatpally, India, Hyderabad, Telangana, India – 500072
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Kobo Biotech Limited
Kobo Biotech Limited has undergone 3 name changes throughout its history. The company was previously known as Kobo Biotech Limited, Avon Organics Ltd, and Avon Lifesciences Limited. The current legal name is Kobo Biotech Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Kobo Biotech Limited | Current |
| Avon Organics Ltd | Previous |
| Avon Lifesciences Limited | Previous |
CIN History of Kobo Biotech Limited
Kobo Biotech Limited has one previous CIN (Corporate Identification Number): L24110AP1993PLC016112. The current CIN is L24110TG1993PLC016112, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24110TG1993PLC016112 | Current |
| L24110AP1993PLC016112 | Previous |
Associated Brands with Kobo Biotech Limited
Kobo Biotech Limited operates two associated brands: Kobo Biotech and Avon Organics. These brands represent Kobo Biotech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality active pharmaceutical ingredients and specialty chemicals for cosmetics and pharmaceutical industries. | kobobiotech.com | |
| Limited information available | avonorganicsltd.com |
Competitors & Alternatives of Kobo Biotech Limited
Brands and companies operating in the same space as Kobo Biotech Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Auditor Details of Kobo Biotech Limited
Kobo Biotech Limited is audited by A N Shah & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A N Shah & Associates | blur-value | blur-value | blur-value |
Board of Directors of Kobo Biotech Limited
Kobo Biotech Limited is currently managed by 6 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Mansukhlal Pitroda | Director | 31 Mar 2018 | 8 Years 3 Months | As last reported |
|
Ajit Annu Kamath
Also directs:
Tack Commosales Llp, Arch Agro Industries Private Limited, Amra Renal Care Limited and 5 more
|
Director | 31 Jan 2009 | 17 Years 5 Months | As last reported |
|
Rajendra Padmanabhan Kaimal
Also directs:
Arch Agro Industries Private Limited, Amra Renal Care Limited, Arch Finechemicals Limited and 5 more
|
Director | 30 May 2013 | 13 Years 1 Months | As last reported |
| Urja Vijaykumar Shah | Director | 27 Dec 2018 | 7 Years 6 Months | As last reported |
| Namrata Amol Randeri | Irp/Rp/Liquidator | 13 Feb 2025 | 1 Years 4 Months | As last reported |
Financials of Kobo Biotech Limited FY 2024 filings available
Kobo Biotech Limited reported revenue of ₹- (up ) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Income | ₹1.52 Lakh | ₹1.52 Lakh | ₹1.66 Lakh | ₹3.59 Lakh | ₹3.44 Lakh | ₹3.39 Lakh |
| Total Income | ₹1.52 Lakh | ₹1.52 Lakh | ₹1.66 Lakh | ₹3.59 Lakh | ₹3.44 Lakh | ₹3.39 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹24.8 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹1,000 | ₹23.01 Lakh | ₹71.54 Lakh | ₹1.39 Cr | ₹1.8 Cr | ₹2.08 Cr |
| Finance Costs | ₹0 | ₹2,000 | ₹13.47 Lakh | ₹10.84 Cr | ₹14.47 Cr | ₹14.44 Cr |
| Depreciation & Amortisation | ₹4.07 Cr | ₹4.07 Cr | ₹4.61 Cr | ₹5.64 Cr | ₹5.88 Cr | ₹6.15 Cr |
| Other Expenses | ₹62.45 Lakh | ₹1.27 Cr | ₹9.79 Cr | ₹1.4 Cr | -₹1.11 Cr | -₹36.47 Lakh |
| Total Expenses | ₹4.94 Cr | ₹5.57 Cr | ₹15.24 Cr | ₹19.27 Cr | ₹21.04 Cr | ₹22.31 Cr |
| Profit Before Exceptional Items & Tax | -₹4.93 Cr | -₹5.55 Cr | -₹15.23 Cr | -₹19.23 Cr | -₹21.01 Cr | -₹22.27 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹2.18 Cr |
| Profit Before Tax | -₹4.93 Cr | -₹5.55 Cr | -₹15.23 Cr | -₹19.23 Cr | -₹21.01 Cr | -₹24.46 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹4.93 Cr | -₹5.55 Cr | -₹15.23 Cr | -₹19.23 Cr | -₹21.01 Cr | -₹24.46 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹4.93 Cr | -₹5.55 Cr | -₹15.23 Cr | -₹19.23 Cr | -₹21.01 Cr | -₹24.46 Cr |
| EBITDA (computed) | -₹85.74 Lakh | -₹1.48 Cr | -₹10.49 Cr | -₹2.75 Cr | -₹65.33 Lakh | -₹1.69 Cr |
| Basic EPS | ₹-2.33 | ₹-2.33 | ₹-6.39 | ₹-8.07 | ₹-8.82 | ₹-10.27 |
| Diluted EPS | ₹-2.33 | ₹-2.33 | ₹-6.39 | ₹-8.07 | ₹-8.82 | ₹-10.27 |
| Metrics | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Assets | ₹71.39 Cr | ₹75.33 Cr | ₹79.19 Cr | ₹230.59 Cr | ₹236.33 Cr | ₹239.45 Cr |
| Non-current Assets | ₹33.52 Cr | ₹37.59 Cr | ₹41.66 Cr | ₹71.36 Cr | ₹76.99 Cr | ₹82.87 Cr |
| Current Assets | ₹37.88 Cr | ₹37.74 Cr | ₹37.53 Cr | ₹159.23 Cr | ₹159.34 Cr | ₹156.58 Cr |
| Property, Plant & Equipment | ₹33.52 Cr | ₹37.59 Cr | ₹41.66 Cr | ₹56.91 Cr | ₹62.54 Cr | ₹68.42 Cr |
| Inventories | ₹18.04 Cr | ₹18.04 Cr | ₹18.04 Cr | ₹53.28 Cr | ₹53.28 Cr | ₹53.28 Cr |
| Trade Receivables | ₹11.97 Cr | ₹11.95 Cr | ₹11.8 Cr | ₹92.47 Cr | ₹93.29 Cr | ₹90.61 Cr |
| Cash & Equivalents | ₹13.77 Lakh | ₹8.41 Lakh | ₹8.34 Lakh | ₹1.52 Cr | ₹8.5 Lakh | ₹8.67 Lakh |
| Equity (Net Worth) | -₹132.91 Cr | -₹127.98 Cr | -₹122.43 Cr | -₹107.2 Cr | -₹87.97 Cr | -₹66.96 Cr |
| Equity Share Capital | ₹23.83 Cr | ₹23.83 Cr | ₹23.83 Cr | ₹23.83 Cr | ₹23.83 Cr | ₹23.83 Cr |
| Borrowings (Non-current) | ₹31.71 Cr | ₹32.66 Cr | ₹33.53 Cr | ₹33.53 Cr | ₹34.93 Cr | ₹34.93 Cr |
| Borrowings (Current) | ₹107.98 Cr | ₹107.18 Cr | ₹107.18 Cr | ₹174.73 Cr | ₹163.93 Cr | ₹149.53 Cr |
| Total Debt (computed) | ₹139.69 Cr | ₹139.84 Cr | ₹140.72 Cr | ₹208.26 Cr | ₹198.86 Cr | ₹184.46 Cr |
| Current Liabilities | ₹167.82 Cr | ₹165.88 Cr | ₹163.31 Cr | ₹299.16 Cr | ₹284.27 Cr | ₹266.38 Cr |
| Total Liabilities | ₹204.3 Cr | ₹203.31 Cr | ₹201.61 Cr | ₹337.79 Cr | ₹324.31 Cr | ₹306.41 Cr |
| Metrics | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Operating Cash Flow | ₹20.36 Lakh | ₹87.46 Lakh | ₹93.76 Cr |
| Investing Cash Flow | ₹0 | ₹0 | ₹25.09 Cr |
| Financing Cash Flow | -₹15 Lakh | -₹87.4 Lakh | -₹120.28 Cr |
| Capital Expenditure | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹20.36 Lakh | ₹87.46 Lakh | ₹93.76 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹5.36 Lakh | ₹6,000 | -₹1.43 Cr |
| Metrics | Q1 FY25 |
|---|---|
| Revenue from Operations | ₹0 |
| Other Income | ₹2.41 Lakh |
| Total Income | ₹2.41 Lakh |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | ₹0 |
| Employee Benefit Expense | ₹6.54 Lakh |
| Finance Costs | ₹0 |
| Depreciation & Amortisation | ₹1.01 Cr |
| Other Expenses | ₹27.71 Lakh |
| Total Expenses | ₹1.35 Cr |
| Profit Before Exceptional Items & Tax | -₹1.33 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹1.33 Cr |
| Total Tax Expense | ₹0 |
| Net Profit | -₹1.33 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | -₹1.33 Cr |
| EBITDA (computed) | -₹31.84 Lakh |
| Basic EPS | ₹0.00 |
| Diluted EPS | ₹0.00 |
Shareholding Pattern of Kobo Biotech Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 44.95%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 55.05% of Kobo Biotech Limited. The company had 7,977 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% |
| Public | 55.05% | 55.05% | 55.05% | 55.05% | 55.05% | 55.05% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 44.95% | 44.95% | 44.95% |
| Public | 55.05% | 55.05% | 55.05% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Kobo Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2015 | Others | ₹2 Cr | Open |
| 11 Jan 2011 | Indian Overseas Bank | ₹20 Cr | Open |
| 10 Jul 2009 | Others | ₹46.76 Cr | Open |
| 29 Feb 2008 | Others | ₹69.5 Cr | Open |
| 13 Apr 2006 | Punjab National Bank | ₹9 Cr | Open |
Total charge records: 36 View all charges
Employees and EPFO Compliance at Kobo Biotech Limited
Kobo Biotech Limited has a workforce of 1 employees as of Apr 09, 2024.
Employee Count & EPFO Data of Kobo Biotech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Kobo Biotech Limited
GSTIN & GST Filing Data of Kobo Biotech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Kobo Biotech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Kobo Biotech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Kobo Biotech Limited
MSME Payment Delays by Kobo Biotech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Kobo Biotech Limited
Subsidiaries & Group Companies of Kobo Biotech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Kobo Biotech Limited with ownership details.
MCA Filings & Documents of Kobo Biotech Limited
MCA Filings & Documents of Kobo Biotech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Kobo Biotech Limited
Frequently Asked Questions about Kobo Biotech Limited
Kobo Biotech Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Kobo Biotech Limited is a company under insolvency, formerly operating as a public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 03 August 1993 and is registered under CIN L24110TG1993PLC016112. Listed on BSE: 531541. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Kobo Biotech Limited reported revenue of ₹1.52 Lakh for FY 2023 (down 8.00% YoY).
The current directors of Kobo Biotech Limited are:
The CIN (Corporate Identification Number) of Kobo Biotech Limited is L24110TG1993PLC016112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Kobo Biotech Limited is listed on BSE with code 531541.